Furthermore, this model creates an inflammatory response utilizing TNF-α/IFN-γ; however, numerous cytokines and interconnecting signaling pathways between intestinal epithelial cells and immune cells determine the effects of psilocybin and other potential therapeutics on inflammation and IBD [86]. The gene discussed is TNF; the disease is inflammatory bowel disease.